AI Summary
Broken String Biosciences has expanded its senior leadership team by hiring Vincent Smith as Chief Technology Officer and Jessica Rich as VP Business Development. Smith will lead the development of INDUCE-seq, a DNA break-mapping platform, while Rich will oversee commercialization strategy. The company aims to achieve its Series A goals and expand globally. Smith has previous experience in DNA sequencing technologies, while Rich will help the company grow in the US, Europe, and Asia.
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the expansion of its senior leadership team with the appointments of Vincent Smith, Ph.D., as Chief Technology Officer and Jessica Rich as VP Business Development.
Bringing significant expertise in their respective fields, Vincent and Jessica’s appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.
As CTO at Broken String, Vince will lead product development, providing leadership and the expertise required to build INDUCE-seq into the gold standard technology for the assessment of off-target effects during gene editing.
Based in Boston, MA, Jessica is Broken String’s first US hire, expanding the Company into this key market. Jessica will oversee the development of the commercialization strategy, enabling the Company to capitalize on early commercial traction and accelerate growth across the US, Europe, and Asia.
Vince’s appointment to Broken String brings extensive experience in the development of innovative DNA sequencing technologies. Prior to joining the team, he held executive-level positions at Base Genomics and Exact Sciences Innovation.
Vince began his career in genomics at Solexa, where he was one of the primary scientists who contributed to the development of the chemistry that underpins Illumina sequencing. As VP of Consumable Development at Illumina, Vince led a global team